At a glance
We’re excited to connect with you at this conference. Prosigna will be in attendance — reach out ahead of the event if you’d like to set up a time to meet.
Learn how the Prosigna Breast Risk of Recurrence test helps guide informed personalized treatment decisions for early-stage, hormone receptor positive (HR+), breast cancer.
Tags
North America
Prosigna Breast